Serum lactic dehydrogenase as a prognostic tool for non-Hodgkin lymphomas
AM Ferraris, P Giuntini and GF Gaetani
Serum LDH levels have been found to be significantly increased in non-
Hodgkin lymphoma (NHL) patients, both histiocytic and lymphocytic. The
duration of survival of NHL negatively correlates with the level of serum
lactic dehydrogenase (LDH), and statistical analysis reveals that patients
with lower levels of LDH have a longer survival rate than the patients with
higher LDH activity, irrespective of their histologic classification. The
analysis of the results by the Test for Trend in Prognosis allows us to
establish that the correlation of the rate of survival and LDH levels is
independent from other clinical parameters.
Volume 54,
Issue 4,
pp. 928-932,
10/01/1979
Copyright © 1979 by The American Society of Hematology